innate immune system
[대역어] 선천 면역
[용어속성] Term
[용어속성] Term
Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children
소아에서 SARS-CoV-2 감염의 급성 및 회복기 동안의 타고난 세포 프로필
Article
[키워드] activated neutrophil
Activated neutrophils
acute phase
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
CD63
cell profile
children
circulating
classical
clinically
convalescent
convalescent phase
coronavirus
Course
COVID-19
dendritic cell
dendritic cells
disease
immune responses
immunological
immunological mechanism
Immunopathogenesis
infected children
Infection
Infectious diseases
Innate
innate immune response
innate immune system
Innate immunity
low-density
Mild
mild SARS-CoV-2 infection
monocyte
Monocytes
natural killer cell
Natural killer cells
neutrophil
Neutrophils
non-classical monocyte
Non-classical monocytes
observé
PCR testing
proportion
reduced
respiratory
SARS-CoV-2
SARS-COV-2 infection
subset
[DOI] 10.1038/s41467-021-21414-x PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-021-21414-x PMC 바로가기 [Article Type] Article
Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology
Review
[키워드] Abnormalities
ACE2
activate
acute respiratory distress
Administered
Against
anti-rheumatic drug
bat
cause
caused
Cell
cell debris
Central nervous system
chemokine
chemokines
China
chronic inflammation
Coagulation
COVID-19
cytokine
cytokine receptor
Cytokine release syndrome
Cytokine storm
Damage-associated molecular patterns
develop
disorders
Disseminated intravascular coagulation
DNA
Effect
endothelial cell damage
Europe
excessive inflammatory response
Favipiravir
G-CSF
global pandemic
Host
human Angiotensin-converting enzyme
IL-1β
IL-6
IL-8
immune system
Infection
Infectious disease
Inflammatory response
inhibit
innate immune system
Innate immunity
involved
IP10
liver
melatonin
mitochondrial
mitochondrial dysfunction
Mitochondrial function
monoclonal antibodies
multiple organ failure
new virus
novel
novel coronavirus diseases (or COVID-19)
occur
organ damage
patients
producing
Proinflammatory cytokine
renal
respiratory infection
resulting
SARS-CoV
SARS-CoV-2
second
serum
storm
Stress
subject
subsequent
suppress
syndrome
TNF-α
Tocilizumab
treatment for COVID-19
Vascular
viral invasion
[DOI] 10.3390/jcm10040801 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/jcm10040801 PMC 바로가기 [Article Type] Review
SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
Review
[키워드] ACE2
acute respiratory distress
Adaptive immune response
angiotensin-converting enzyme 2
Antibody titers
Asymptomatic
CD147
challenge
characterized
cleavage
CLR
Coronavirus disease-19
COVID-19
Cytokine storm syndrome
displaying
domain
dysregulation
Effect
Frame
host immune system
immune antagonism
Immunopathogenesis
immunopathology
immunotherapies
implicated
include
innate immune system
Interaction
life-threatening
mechanism
myeloid
non-structural protein
Novel coronavirus
NRP1
nucleic acid vaccine
opportunity
Other
pathology
peptide
Potential
receptor
reduced
Research
respiratory
SARS-CoV-2
SARS-COV-2 infection
spike glycoprotein
syndrome
Therapeutics
Therapies
therapy
TMPRSS2
Treatment
Vaccine
Vaccines
viral spread
Viral variants
virus
Wuhan, China
[DOI] 10.3390/idr13010013 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/idr13010013 PMC 바로가기 [Article Type] Review
Can COVID-19 Cause Flare-Ups of Acute Hepatitis B? An Atypical Presentation of COVID-19 with Acute Hepatitis B
Case Report
[키워드] addition
Admission
ambulance service
Ammonium
Antigen
Apoptosis
blood test
Brain
Can
cause
caused
cell damage
chest X-ray
Coagulation
cough
COVID-19
COVID-19 patients
creatinine
cytotoxic T lymphocyte
Department
died
edema
elevated
Emergency
event
febrile
Fever
fixed
hepatitis B
hepatocyte
Infection
initial
innate immune system
liver
Liver damage
lung infiltrates
lung involvement
male
Necrosis
occurred
past medical history
Pathogenesis
pathophysiological
Patient
PCR testing
positive
presentation
Pupils
SARS-CoV-2
serological test
serology
Support
Swab
the patient
transaminases
urea
viral replication
X-ray
[DOI] 10.1155/2021/8818678 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1155/2021/8818678 PMC 바로가기 [Article Type] Case Report
Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data
UK Biobank 데이터에서 유전적 변이가 COVID-19 관련 사망 위험을 증가시키는 것으로 확인되었습니다.
Primary Research
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
associations
bronchial epithelial cell
cardiovascular disease
cardiovascular diseases
caused
chromosome
chromosomes
CLUAP1
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 mortality
dataset
death
deaths
DES
DNAH7
downregulated gene
dysfunction
ENhance
epithelial cells
ethnic group
Ethnic groups
Factors
Genetic
genetic factors
Genetic variant
genetic variants
Genome-wide association study
genome-wide significant
GWAS
heterogeneous
Host
Host genetic factors
human bronchial epithelial cells
identify
increased risk
infected case
infecting
innate immune system
interactions
male
mitochondrial
mitochondrial dysfunction
molecular
Mortality
pathogenesis of COVID-19
power
Replication
reported
respiratory
Result
risk factor
risk of COVID-19
risk of death
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
severity
significantly
SPEG
STXBP5
supplementary material
susceptibility
susceptibility loci
the patient
therapeutic options
thromboembolic
thromboembolic disease
TOMM7
Traditional
UK biobank
UK Biobank data
variant
WSB1
[DOI] 10.1186/s40246-021-00306-7 PMC 바로가기 [Article Type] Primary Research
[DOI] 10.1186/s40246-021-00306-7 PMC 바로가기 [Article Type] Primary Research
Complement Activation in Kidneys of Patients With COVID-19
COVID-19 환자의 신장에서 보체 활성화
Immunology
[키워드] activated
Activation
acute kidney failure
acute respiratory syndrome
affected
Alternative pathway
analyzed
Antigen
arteries
Arterioles
Artery
Autopsy
basement membrane
biopsies
biopsy
C1q
C3c
C4d
C5b-9
Capillaries
capillary
Cell
classical pathway
cleavage
clinical setting
Coagulation
collateral tissue
collectin
complement
Complement activation
Complement pathway
complement system
complement—immunological term
complex
controls
COVID-19
COVID-19 patients
Critically ill
Critically ill patient
critically ill patients
CTRL
deregulated
develop
Disseminated intravascular coagulation
dominant
Endothelial cell
endothelial injury
Factor
Frequency
glomerular
hemolytic uremic syndrome
highest
immune cell responses
immune response
immunohistochemistry
In situ hybridization
in some
infection with COVID-19
Injury
innate immune system
intravascular coagulation
investigated
involved
kidney
Kidney failure
kidneys
lectin
lectin pathway
lectin pathway activation
lung
marker
MASP-2
membrane
Most patient
Most patients
nuclear
occur
opsonization
organ
pathway
Patient
patients with COVID-19
PCNA
peritubular
peritubular capillaries
peritubular capillary
plasma
Platelet
Platelets
positive platelets
Prevent
proliferation
Protein
protocol
renal
renal arteries
renal tissue
respiratory
SARS-CoV-2
Severe acute respiratory syndrome
specimen
specimens
subsequent
therapy
Thrombus
thrombus formation
tissue
tissue injury
Transplant
Treatment
triggering
uremic syndrome
virus
viruses
with COVID-19
worsening
[DOI] 10.3389/fimmu.2020.594849 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2020.594849 PMC 바로가기 [Article Type] Immunology
Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice
혈청 아밀로이드 P는 생쥐에서 단일 가닥 RNA 유발 폐 염증, 폐 손상 및 사이토카인 폭풍을 억제합니다
Research Article
[키워드] accumulation
aggregate
alveolar
amyloid
animal model
animal models
aspiration
Blood clots
cause
clinical trials
clot
COVID-19
cytokine
Cytokine storm
D-dimer
D-dimer level
D-dimer levels
disease
Efficacy
Extracellular
female
fibrosis
Genome
Hyperactivation
IL-12p70
IL-1β
IL-23
IL-27
IL-6
immune
increase in
induce
Infection
inflammatory cell
inflammatory cells
Inflammatory cytokine
Inflammatory cytokines
inflammatory immune cells
inhibit
innate immune system
intraperitoneal injection
Intraperitoneal injections
lung
lung alveolar
lung damage
Lung inflammation
male
mice
mononuclear cells
Peripheral blood
Protein
reduced
RNA
SARS-CoV-2
sequence
serum
serum amyloid
serum cytokine
serum cytokine levels
Serum protein
severe COVID-19 symptom
severe symptom
ssRNA
Symptom
Symptoms
therapeutic
upregulation
virus
women
[DOI] 10.1371/journal.pone.0245924 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0245924 PMC 바로가기 [Article Type] Research Article
Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
Review
[키워드] ACE2
acute respiratory syndrome
angiotensin-converting enzyme 2
Anti-viral immunity
c-lectin type receptor
Can
carbohydrate
catastrophic
Cell
CLR
CLRs
contribute
coronavirus disease
Coronavirus-2
COVD-19
COVID-19
demonstrated
Dipeptidyl peptidase-4
engage
ezrin
Glucose
glucose-regulated protein 78
glycosylated
glycosylation
GRP78
Health
host cell
immune
immunopathological
independent
Infection
Inflammation
innate immune system
Interaction
mannose receptor
Multiple
N-glycans
non-immune
NRP1
Occurrence
Protein
receptor
Recognition
regulated
reported
responsible
S protein
SARS-CoV-2
SARS-CoV-2 S protein
Spike protein
Spread
susceptibility
the S protein
therapeutic target
TLR
TLRs
Toll-like receptor
viral clearance
viral surface
[DOI] 10.3390/ijms22030992 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ijms22030992 PMC 바로가기 [Article Type] Review
Observations on the use of Bruton’s tyrosine kinase inhibitors in SAR-CoV-2 and cancer
SAR-CoV-2 및 암에서 Bruton의 티로신 키나제 억제제 사용에 대한 관찰
Letter to the Editor
[키워드] Acalabrutinib
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
Bruton’s tyrosine kinase
BTK
BTK inhibitor
Cancer
circulation
Coronavirus-2
COVID-19
COVID-19 patient
COVID-19 patients
Cytokines
determine
drug
Ibrutinib
IL-1β
infected with SARS-CoV-2
inhibitors
innate immune system
Lung disease
Lung injury
observation
Patient
potential mechanism
pro-inflammatory cytokine
pro-inflammatory cytokines
PROTECT
pulmonary injury
respiratory
SAR-CoV-2
SARS-CoV-2
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
tyrosine
tyrosine kinase inhibitor
understanding
[DOI] 10.1186/s13045-020-00999-8 PMC 바로가기 [Article Type] Letter to the Editor
[DOI] 10.1186/s13045-020-00999-8 PMC 바로가기 [Article Type] Letter to the Editor